Bicellar systems as a new colloidal delivery strategy for skin

The presented work evaluates the use of bicellar systems as new delivery vectors for controlled release of compounds through the skin. Two different active principles were introduced into the bicellar systems: diclofenac diethylamine (DDEA) and flufenamic acid (Ffa). Bicellar systems are discoidal aggregates formed by long and short alkyl chain phospholipids. Characterization of the bicellar systems by dynamic light scattering (DLS) and cryogenic transmission electron microscopy (Cryo-TEM) showed that particle size decreased when DDEA was encapsulated and increased when Ffa was included in the bicellar systems. Percutaneous absorption studies demonstrated a lower penetration of DDEA and Ffa through the skin when the drugs were included in the bicellar systems than when the drugs were applied in an aqueous solution (DDEA) and in an ethanolic solution (Ffa); the reduction in penetration was more pronounced with Ffa. These bicellar systems may have retardant effects on percutaneous absorption, which result in a promising strategy for future drug or cosmetic delivery applications.

Graphical abstractFigure optionsDownload full-size imageDownload as PowerPoint slideHighlights► Bicelles emerge as smart colloidal systems for drug delivery. ► These systems have potential retardant effects on percutaneous absorption. ► Bicellar systems are able to encapsulated different drugs. ► Bicelles may be useful to scientists engaged in colloid science and offer a new tool for different applications in topical delivery.